Revance Therapeutics (RVNC) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Revance Therapeutics (RVNC)

3.65

-0.00 (0.00%)

as of Feb 5, 2025, 12:00:00 am Market Open.

2 watching

BUY

There's demand for products to improve skin care and appearance, because people want to look good.

DON'T BUY

Abbvie as competition Abbvie's CEO hasn't turned the juice on Allergan (a company ABBV bought last year) and he's very competitive. When he turns it on, it will hurt EVNC. Be careful with RVNC. He wishes he liked Revance more. He knows this group (aesthetics) and Abbvie produces the popular Botox.

Showing 1 to 2 of 2 entries

Revance Therapeutics (RVNC) Frequently Asked Questions

What is Revance Therapeutics stock symbol?

Revance Therapeutics is a American stock, trading under the symbol RVNC (previously RVNC-Q on Stockchase) on the NASDAQ (RVNC). It is usually referred to as NASDAQ:RVNC or RVNC

Is Revance Therapeutics a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on RVNC (previously RVNC-Q on Stockchase) on Stockchase. Read the latest expert commentary for Revance Therapeutics.

Is Revance Therapeutics a good investment or a top pick?

Revance Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Revance Therapeutics.

Why is Revance Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Revance Therapeutics.

Is Revance Therapeutics worth watching?

Revance Therapeutics is covered by Stockchase experts and is worth watching.

What is Revance Therapeutics stock price?

On 2025-02-05, Revance Therapeutics (RVNC) stock closed at a price of $3.65.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Revance Therapeutics (RVNC)